Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2023 May 31;13:1228879. doi: 10.3389/fonc.2023.1228879

Corrigendum: Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022

Jiahua Liu 1,, Junnan Ma 1,, Jiarong Zhang 1, Chengming Li 1, Bowen Yu 1, Hyok Chol Choe 1, Kaiyue Ding 1, Liu Zhang 1, Lin Zhang 1,*
PMCID: PMC10264800  PMID: 37324024

In the published article, there was an error in the Funding statement. In the Funding statement, we left out a funding. The original Funding statement is “This work was supported by grants from the National Natural Science Foundation of China (No. 81873195), the Liaoning Revitalization Talents Program (XLYC1907113), the Natural Science Foundation of Liaoning Province (2023010109-JH2/1013), and the Distinguished Young Scholars in Dalian (2022RJ19).”. The correct Funding statement appears below.

Funding

This work was supported by grants from the National Natural Science Foundation of China (No.81873195), the Liaoning Revitalization Talents Program (XLYC1907113), the Natural Science Foundation of Liaoning Province (2023010109-JH2/1013), the Distinguished Young Scholars in Dalian (2022RJ19), and the Dalian Medical University Foundation for Teaching Reform Project of Undergraduate Innovative Talents Training (111906010210).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES